정밀진단 시장 규모, 점유율, 성장 분석 : 제품 유형별, 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Global Precision Diagnostics Market size was valued at USD 68.07 billion in 2023 and is poised to grow from USD 80.59 billion in 2024 to USD 311.26 billion by 2032, growing at a CAGR of 18.4% during the forecast period (2025-2032).

Precision diagnostics is revolutionizing healthcare by providing tailored, timely insights into patients' health issues, particularly in diabetes and cancer treatment. Given the escalating incidence of cancer and neurological disorders, demand for precision medicine is set to soar. The National Cancer Institute projects a staggering increase of 29.5 million new cancer cases by 2031, alongside a 16.4 million rise in cancer-related fatalities. Advances in gene therapy and precision treatments for conditions like cancer, tuberculosis, and Alzheimer's are expected to drive significant revenue growth. The customizable nature of precision diagnostics and therapies is a critical advantage, allowing for personalized treatment approaches rather than a generic solution, thereby enhancing patient outcomes and healthcare efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Diagnostics Market Segmental Analysis

Global Precision Diagnostics Market is segmented by Product Type, Type, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software & Services. Based on Type, the market is segmented into Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Others. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Infectious Diseases and Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is being driven significantly by the rising demand for personalized therapy, which has gained traction in recent years. Essential tools such as genetic testing and genome sequencing are pivotal in unraveling the molecular foundations of various diseases. In many European nations, there is a proactive approach to screening for genetic disorders, as early detection can mitigate symptoms and lessen disease severity. Additionally, the COVID-19 pandemic highlighted the importance of diagnostic testing in managing outbreaks. Pharmaceutical and biotech firms are actively pursuing preclinical and clinical trials for innovative therapies, including plasma and immunotherapy. This momentum is expected to fuel market growth throughout the forecast period.

Restraints in the Global Precision Diagnostics Market

The Global Precision Diagnostics market faces several restraints that could impede its growth potential, primarily due to a lack of awareness and substantial costs associated with research and development. High R&D expenses deter innovation and advancement in precision diagnostics. While accurate diagnosis remains a top priority for healthcare providers, challenges such as the demand for quicker test results, inefficiencies in current testing methods, and regulatory hurdles for new test kit development further complicate market progress. Additionally, the strict regulatory landscape in many nations continues to pose significant barriers, ultimately hampering the overall expansion of the precision diagnostics sector.

Market Trends of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is experiencing a significant upward trend, driven primarily by the alarming increase in cancer prevalence worldwide. As cancer cases rise, there is an intensified focus on enhancing detection, prevention, and treatment protocols. Innovations such as Next Generation Sequencing (NGS) and the integration of extensive genomic data are revolutionizing the diagnostic landscape, leading to more tailored and effective therapeutic strategies. This fusion of technological advancements and a growing demand for precision medicine is poised to fuel robust growth in the market throughout the forecast period, positioning it as a critical component of modern healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Precision Diagnostics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Consumables
  • Reagents
  • Kits
  • Assays
• Instruments
  • Next-Generation Sequencing (NGS) Systems
  • Polymerase Chain Reaction (PCR) Systems
  • Mass Spectrometry Systems
  • Others
• Software & Services
  • Data Analysis Software
  • Bioinformatics Services
  • Consulting Services

Global Precision Diagnostics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

Global Precision Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others
• Cardiology
• Neurology
• Infectious Diseases
• Others

Global Precision Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Precision Diagnostics Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations